Joy Bauch

2.7k citations

20 papers · 751 indexed · h-index 12

Impact in

Oncology
- Cancer-related Molecular Pathways
- Lung Cancer Research Studies
Molecular Biology
- Cell death mechanisms and regulation
- Cancer therapeutics and mechanisms
- RNA Interference and Gene Delivery
- Protein Degradation and Inhibitors

Papers in ⓘ

Oncology 9
- HER2/EGFR in Cancer Research 3
- Cancer-related Molecular Pathways 2
Behavioral Neuroscience 1

Co-authors: Saul H. Rosenberg (12 shared papers)Kennan C. Marsh (11 shared papers)Stephen W. Fesik (4 shared papers)Steven W. Elmore (5 shared papers)Christin Tse (4 shared papers)Xiufen Yang (2 shared papers)Jessica Adickes (3 shared papers)Xilu Wang (2 shared papers)
Journals: Bioorganic & Medicinal Chemistry Letters (4 papers)Clinical Cancer Research (2 papers)Journal of Medicinal Chemistry (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)Blood (2 papers)
Partner nations: United States United Kingdom Germany

In The Last Decade

Joy Bauch

20 papers receiving 733 citations

Peers

Countries citing papers authored by Joy Bauch

Since Specialization

Citations

This map shows the geographic impact of Joy Bauch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Joy Bauch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Joy Bauch more than expected).

Fields of papers citing papers by Joy Bauch

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Joy Bauch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Joy Bauch. The network helps show where Joy Bauch may publish in the future.

Co-authors

The 25 scholars most cited alongside Joy Bauch, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Joy Bauch Line = papers co-authored together Joy Bauch links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Discovery of an Orally Bioavailable Small Molecule Inhibitor of Prosurvival B-Cell Lymphoma 2 Proteins Journal of Medicinal Chemistry ·Cheol‐Min Park, Milan Bruncko, Jessica Adickes, Joy Bauch, Hong Ding, Aaron Kunzer, Kennan C. Marsh, Paul Nimmer, Alexander R. Shoemaker, Xiaohong Song, Stephen K. Tahir, Christin Tse, Xilu Wang, Michael Wendt, Xiufen Yang, Haichao Zhang, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore	2008	228
2	Activity of the Bcl-2 Family Inhibitor ABT-263 in a Panel of Small Cell Lung Cancer Xenograft Models Clinical Cancer Research ·Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes, Scott Ackler, Marion Refici, Debra C. Ferguson, Anatol Oleksijew, Jacqueline M. O’Connor, Baole Wang, David J. Frost, Joy Bauch, Kennan C. Marsh, Steven K. Tahir, Xiufen Yang, Christin Tse, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore	2008	155
3	ABT-263 and rapamycin act cooperatively to kill lymphoma cells in vitro and in vivo Molecular Cancer Therapeutics ·Scott Ackler, Xiao Yu, Michael J. Mitten, Kelly Foster, Anatol Oleksijew, Marion Refici, Sally Schlessinger, Baole Wang, Sanjay R. Chemburkar, Joy Bauch, Christin Tse, David J. Frost, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore, Alex R. Shoemaker	2008	64
4	Pyridone-Containing farnesyltransferase inhibitors: synthesis and biological evaluation Bioorganic & Medicinal Chemistry Letters ·Lisa Hasvold, Weibo Wang, Stephen L. Gwaltney, Todd W. Rockway, Lissa T.J. Nelson, Robert A. Mantei, Stephen A. Fakhoury, Gerard M. Sullivan, Qun Li, Nan‐Horng Lin, Le Wang, Haiying Zhang, Jerome Cohen, Wen‐Zhen Gu, Kennan C. Marsh, Joy Bauch, Saul H. Rosenberg, Hing L. Sham	2003	64
5	Zotarolimus, a Novel Sirolimus Analogue With Potent Anti-proliferative Activity on Coronary Smooth Muscle Cells and Reduced Potential for Systemic Immunosuppression Journal of Cardiovascular Pharmacology ·Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets, Steve Ballaron, James M. Trevillyan, Sandra E. Burke, Teresa A. Rosenberg, Cindy Henry, Rolf Wagner, Joy Bauch, Kennan Marsh, Thomas A. Fey, Gin C. Hsieh, Donna M. Gauvin, Karl W. Mollison, George W. Carter, Stevan W. Djurić	2007	55
6	Design, Synthesis, and Biological Activity of 4-[(4-Cyano-2-arylbenzyloxy)-(3-methyl-3H-imidazol-4-yl)methyl]benzonitriles as Potent and Selective Farnesyltransferase Inhibitors Journal of Medicinal Chemistry ·Le Wang, Gary T. Wang, Xilu Wang, Yunsong Tong, Gerry Sullivan, David Park, Nicholas M. Leonard, Qun Li, Jerry D. Cohen, Wen‐Zhen Gu, Haiying Zhang, Joy Bauch, Clarissa G. Jakob, Charles W. Hutchins, Vincent S. Stoll, Kennan C. Marsh, Saul H. Rosenberg, Hing L. Sham, Nan‐Horng Lin	2004	29
7	Plasma and cerebrospinal fluid pharmacokinetics of ABT-888 after oral administration in non-human primates Cancer Chemotherapy and Pharmacology ·Jodi A. Muscal, Patrick A. Thompson, Vincent L. Giranda, Brian D. Dayton, Joy Bauch, Terzah M. Horton, Leticia McGuffey, Jed G. Nuchtern, Robert C. Dauser, Brian Gibson, Susan M. Blaney, Jack M. Su	2009	28
8	Conditioning of drug‐induced immunomodulation in human volunteers: A European Collaborative Study British Journal of Clinical Psychology ·Clemens Kirschbaum, Lea Jabaaij, Angelika Buske-Kirschbaum, Jürgen Hennig, Marieke T. Blom, Kristien Dorst, Joy Bauch, R. DiPauli, Gerd Schmitz, R. E. Ballieux, Dirk H. Hellhammer	1992	22
9	Antitumor Activity of Orally Bioavailable Farnesyltransferase Inhibitor, ABT-100, Is Mediated by Antiproliferative, Proapoptotic, and Antiangiogenic Effects in Xenograft Models Clinical Cancer Research ·Debra C. Ferguson, Luis E. Rodrı́guez, Joann P. Palma, Marion Refici, Kenneth Jarvis, Jacqueline M. O’Connor, Gerard M. Sullivan, David J. Frost, Kennan Marsh, Joy Bauch, Haiying Zhang, Nan‐Horng Lin, Saul H. Rosenberg, Hing L. Sham, Ingrid B.J. Joseph	2005	20
10	Discovery of potent imidazole and cyanophenyl containing farnesyltransferase inhibitors with improved oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Yunsong Tong, Nan‐Horng Lin, Le Wang, Lisa Hasvold, Weibo Wang, Nicholas M. Leonard, Tongmei Li, Qun Li, Jerry D. Cohen, Wen‐Zhen Gu, Haiying Zhang, Vincent S. Stoll, Joy Bauch, Kennan C. Marsh, Saul H. Rosenberg, Hing L. Sham	2003	18
11	Use of the H₃receptor antagonist radioligand [³H]‐A‐349821 to revealin vivoreceptor occupancy of cognition enhancing H₃receptor antagonists British Journal of Pharmacology ·T. R. Miller, Ivan Milicic, Joy Bauch, J. Du, Bruce W. Surber, K. E. Browman, Kennan C. Marsh, M. D. Cowart, JD Brioni, T. A. Esbenshade	2009	16
12	Endothelin receptor antagonist has limited access to the fetal compartment during chronic maternal administration late in pregnancy Life Sciences ·Larry G. Thaete, Saira Khan, Sylvia Synowiec, Brian D. Dayton, Joy Bauch, Mark G. Neerhof	2012	13
13	Synthesis of 1H-pyridin-2-one derivatives as potent and selective farnesyltransferase inhibitors Bioorganic & Medicinal Chemistry Letters ·Le Wang, Nan‐Horng Lin, Qun Li, Rodger F. Henry, Haiying Zhang, Jerome Cohen, Wen‐Zhen Gu, Kennan C. Marsh, Joy Bauch, Saul H. Rosenberg, Hing L. Sham	2004	10
14	Potent inhibitors of protein farnesyltransferase: Heteroarenes as cysteine replacements Bioorganic & Medicinal Chemistry Letters ·Shen Wang, Stephen A. Fakhoury, Greg Donner, Kenneth J. Henry, Jang Lee, Haichao Zhang, Jerry D. Cohen, Robert R. Warner, Badr Saeed, Sajeev Cherian, Stephen K. Tahir, Peter Kovar, Joy Bauch, Shi‐Chung Ng, Kennan Marsh, Hing L. Sham, Saul H. Rosenberg	1999	7
15	Plasma and cerebrospinal fluid pharmacokinetics of intravenously administered ABT-751 in non-human primates Cancer Chemotherapy and Pharmacology ·Steve Y. Cho, Elizabeth Fox, Cynthia Lester McCully, Joy Bauch, Kennan C. Marsh, Frank M. Balis	2006	5
16	The Bcl-2 Family Inhibitor ABT-263 Shows Significant but Reversible Thrombocytopenia in Mice. Blood ·Alex R. Shoemaker, Michael J. Mitten, Jessica Adickes, Anatol Oleksijew, Haichao Zhang, Joy Bauch, Kennan Marsh, David J. Frost, David J. Madar, Christin Tse, Stephen W. Fesik, Saul H. Rosenberg, Steven W. Elmore	2006	5
17	Evaluation of the Oral Antimitotic Agent (ABT-751) in Dogs with Lymphoma Journal of Veterinary Internal Medicine ·Mitchell Silver, A.W. Rusk, Brenda Phillips, Eduardo Beck, Marcin Jankowski, J. Philibert, Klaus-Jürgen Hahn, E. P. Hershey, Evelyn McKeegan, Joy Bauch, Andrew Krivoshik, C. Khanna	2012	4
18	Tumour‐selective antivascular effects of the novel anti‐mitotic compound A‐318315: Anin vivorat regional haemodynamic study Clinical and Experimental Pharmacology and Physiology ·Jason A. Segreti, Kristin A. Brooks, Kennan C. Marsh, Joy Bauch, Yan Lan, C. Thomas Lin, Saul H. Rosenberg, Hing L. Sham, Glenn A. Reinhart, Bryan F. Cox, James S. Polakowski	2010	3
19	Ex VivoAssessment of Immunosuppression in Undiluted Whole Blood from Pigs Dosed with Tacrolimus (FK506) Clinical Immunology ·Yung‐Wu Chen, Morey L. Smith, Michael P. Sheets, Stephen J. Ballaron, James M. Trevillyan, Thomas A. Fey, Donna M. Gauvin, Robin M. Kolano, Melissa Pong, Gin C. Hsieh, Joy Bauch, Kennan C. Marsh, George Carter, Jay R. Luly, Stevan W. Djurić, Karl W. Mollison	1999	3
20	Bcl-2 Family Protein Inhibitors Induce a Unique Thrombocytopenia In Vivo. Blood ·Steven W. Elmore, Joy Bauch, Ryan M. Fryer, Laurie Iciek, Kennan C. Marsh, Sherry J. Morgan, Richard Alan Nelson, Glenn A. Reinhart, Morey L. Smith, Chris Tse, Saul H. Rosenberg	2006	2

About Joy Bauch

Joy Bauch is a scholar working on Oncology, Behavioral Neuroscience, Molecular Biology, Sensory Systems and Immunology, having authored 20 papers that have together received 751 indexed citations. Recurring topics across this work include Protein Kinase Regulation and GTPase Signaling (5 papers), Cancer therapeutics and mechanisms (3 papers), HER2/EGFR in Cancer Research (3 papers), Signaling Pathways in Disease (2 papers), Retinoids in leukemia and cellular processes (2 papers), Immune Cell Function and Interaction (2 papers), Cancer-related Molecular Pathways (2 papers) and Click Chemistry and Applications (2 papers). The work is most often cited by research in Oncology (182 citations), Molecular Biology (456 citations), Organic Chemistry (172 citations), Toxicology (18 citations) and Genetics (53 citations). Joy Bauch has collaborated with scholars based in United States, United Kingdom and Germany. Frequent co-authors include Saul H. Rosenberg, Kennan C. Marsh, Stephen W. Fesik, Steven W. Elmore, Christin Tse, Xiufen Yang, Jessica Adickes, Xilu Wang, David J. Frost and Marion Refici. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Clinical Cancer Research, Journal of Medicinal Chemistry, Cancer Chemotherapy and Pharmacology and Blood.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact